{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:48:37Z","timestamp":1777884517913,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Technology"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Objective: To report a case of chlordiazepoxide-associated Stevens-Johnson syndrome (SJS). Case Summary: This case provides insight into a serious adverse drug reaction secondary to a drug not commonly associated with SJS. A 29-year-old female presented with a 4-day history of rash and pruritus. The rash started on her arms and spread all over her body. The patient was started on chlordiazepoxide 3\u00bd weeks ago. On examination, there were multiple, raised, round erythematous lesions in various stages of healing. Skin erosions were noted on her lips and buccal mucosa. However, the rash did not involve the conjunctiva, inner ears, or genitalia. The patient was discharged home with a follow-up appointment with dermatology and instructions to discontinue chlordiazepoxide. Two days after her initial presentation, the patient\u2019s rash spread to her eyes and genitalia. A painful, white film developed on her tongue, and she was unable to tolerate oral intake. She was emergently sent back to hospital and transferred to a Burn Unit. The biopsy report revealed full-thickness necrotizing keratinocytes in the epidermis consistent with SJS. Discussion: To our knowledge, there is only one other case report of chlordiazepoxide-associated SJS. Chlordiazepoxide is thought to be the cause of this patient\u2019s biopsy-confirmed SJS and overall presentation. SJS is a rare but serious condition that is usually a result of drug exposure. Conclusions: The close temporal relationship between chlordiazepoxide initiation and onset of SJS provides a convincing theory as to the etiology of SJS in our patient.<\/jats:p>","DOI":"10.1177\/8755122517753595","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T16:52:41Z","timestamp":1516207961000},"page":"82-85","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Stevens-Johnson Syndrome Associated With Chlordiazepoxide"],"prefix":"10.1177","volume":"34","author":[{"given":"Tara","family":"Jawaro","sequence":"first","affiliation":[{"name":"Robert Wood Johnson University Hospital, New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr","family":"Pistun","sequence":"additional","affiliation":[{"name":"Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepali","family":"Dixit","sequence":"additional","affiliation":[{"name":"Robert Wood Johnson University Hospital, New Brunswick, NJ, USA"},{"name":"Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"bibr1-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1590\/S0103-507X2006000300012"},{"key":"bibr2-8755122517753595","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.0057"},{"key":"bibr3-8755122517753595","first-page":"207","volume":"149","author":"Naldi L","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"key":"bibr4-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.003."},{"key":"bibr5-8755122517753595","first-page":"995","volume":"24","author":"Oliveira A","year":"2011","journal-title":"Acta Med Port"},{"key":"bibr6-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1016\/S1726-4901(09)70150-9"},{"key":"bibr7-8755122517753595","unstructured":"Chlordiazepoxide [package insert]. Sellerville, PA: Teva Pharmaceuticals; 2012."},{"key":"bibr8-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1111.x"},{"key":"bibr9-8755122517753595","first-page":"236","volume":"17","author":"Loncar C","year":"2005","journal-title":"Psychiatr Danub"},{"key":"bibr10-8755122517753595","unstructured":"US Food and Drug Administration. FDA drug safety communication: FDA warns of serious skin reactions with the anti-seizure drug Onfi (clobazam) and has approved label changes. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm377204.htm. Updated January 15, 2016. Accessed May 24, 2017."},{"key":"bibr11-8755122517753595","first-page":"55","volume":"26","author":"S\u00e1nchez I","year":"1998","journal-title":"Allergol Immunopathol"},{"key":"bibr12-8755122517753595","first-page":"187","volume":"56","author":"Lagnaoui R","year":"2001","journal-title":"Therapie"},{"key":"bibr13-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02654.x"},{"key":"bibr14-8755122517753595","unstructured":"European Medicines Agency. Tetrazepam-containing medications. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/referrals\/Tetrazepam_containing_medicinal_products\/human_referral_prac_000015.jsp&mid=WC0b01ac05805c516f. Accessed May 24, 2017."},{"key":"bibr15-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1850-y"},{"key":"bibr16-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"bibr17-8755122517753595","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"}],"container-title":["Journal of Pharmacy Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/8755122517753595","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/8755122517753595","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/8755122517753595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:28:05Z","timestamp":1777602485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/8755122517753595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1177\/8755122517753595"],"URL":"https:\/\/doi.org\/10.1177\/8755122517753595","relation":{},"ISSN":["8755-1225","1549-4810"],"issn-type":[{"value":"8755-1225","type":"print"},{"value":"1549-4810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]}}}